IDEX IEX Health & Science Technologies — Other segment expenses
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by IDEX in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The official record: IDEX’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about IDEX's health & science technologies — other segment expenses.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is IDEX's health & science technologies — other segment expenses?
- IDEX (IEX) reported health & science technologies — other segment expenses of -$61.1M in Q1 2026.
- How has IDEX's health & science technologies — other segment expenses changed year-over-year?
- IDEX's health & science technologies — other segment expenses decreased by 15.5% year-over-year, from -$52.9M to -$61.1M.
- What is the long-term trend for IDEX's health & science technologies — other segment expenses?
- Over 3 years (2022 to 2025), IDEX's health & science technologies — other segment expenses has grown at a 4.0% compound annual growth rate (CAGR), from -$188.5M to -$212.2M.
- What does health & science technologies — other segment expenses mean?
- Captures operating expenses specific to the Health and Science Technologies segment that are not classified as cost of sales. This typically includes segment-specific research and development, selling, general, and administrative costs.